With the aim of enabling clinicians to design personalized therapeutic options according to patients’ age, in this study we investigated the relation between different threshold values of ki67, involved for defining breast cancer molecular subtypes along with other prognostic biomarkers, and the predisposition to develop a breast cancer-related invasive disease event (IDE) at different ages. Here, MKI67 is linked to breast carcinoma.